Pneumonia in the immunocompromised host: The role of bronchoscopy and newer diagnostic techniques

Seminars in Respiratory Infections

Volumn 15, Issue 2, 2000, Pages 144-161

  Baselski, Vickie ^a   Mason, Kimberly ^a,b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b Department of Pathology ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN DETECTION; ARTICLE; ASPERGILLUS; ASPIRATION; CANDIDA; CLINICAL PROTOCOL; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC VALUE; FIBEROPTIC BRONCHOSCOPY; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HIGH RISK PATIENT; HUMAN; IMMUNE DEFICIENCY; LUNG LAVAGE; NONHUMAN; OPEN LUNG BIOPSY; OPPORTUNISTIC INFECTION; PNEUMOCYSTIS CARINII; PNEUMONIA; PRIORITY JOURNAL; SERODIAGNOSIS; SPUTUM ANALYSIS; TOXOPLASMA;

EID: 0033850697     PISSN: 08820546     EISSN: None     Source Type: Journal    
DOI: 10.1053/srin.2000.9596     Document Type: Article

References (62)

1. Respiratory disease in the immunosuppressed patient
2. The lung in the immunocompromised patient. Infectious complications Parta 2
3. Noninfectious lung disease in the immunocompromised host
4. The lung in the immunocompromised patient. Infectious complications Part 1
5. Pneumocystis pneumonia: Clinical presentation and diagnosis in patients with and without acquired immune deficiency syndrome
6. Pneumocystic carinii pneumonia in patients without acquired immunodeficiency syndrome: Associated illnesses and prior corticosteroid therapy
7. Respiratory disease trends in the pulmonary complications of HIV infection study cohort
8. Pulmonary complications of HIV infection. Autopsy findings
9. Pyogenic bacterial pneumonia in human-immunodeficiency virus-infected inpatients: A clinical, radiological, microbiological, and epidemiological study
10. Infection by Rhodococcus equi in a patient with AIDS: Histological appearance mimicking Whipple's disease and Mycobacterium avium - Intracellulare infection
11. Corynebacterium pseudodiphtheriticum: An easily missed respiratory pathogen in HIV-infected patients
12. Nocardiosis after bone marrow transplantation: A retrospective study
13. Chryseobacterium meningosepticum: An emerging pathogen among immunocompromised adults. Report of 6 cases and literature review
14. Unusual clinical presentation of infection due to Flavimonas oryzihabitans
15. Bronchoscopic diagnosis of pneumonia
16. Viral and Pneumocystis infections of the lung in the immunocompromised host
17. Recovery of viruses other than cytomegalovirus from bronchoalveolar lavage fluid
18. Adenovirus infection in the lung results in graft failure after lung transplantation
19. Respiratory syncytial virus pneumonia in hospitalized adult patients with leukemia
20. Opportunistic fungal pneumonia
21. Emerging fungal pathogens: Evolving challenges to immunocompromised patients for the twenty first century
22. Toxoplasmosis in kidney transplant recipients: Report of six cases and review
23. Opportunistic Strongyloides stecoralis infection in lymphoma patients. Report of a case and review of the literature
24. Pneumonia in the compromised host including cancer patients and transplant patients
25. Analysis of bronchoalveolar lavage specimens from immunocompromised patients with a protocol applicable in the microbiology laboratory
26. Infectious disease physicians rate microbiology services and practices
27. Bronchoalveolar lavage during neutropenic episodes: Diagnostic yield and cellular pattern
28. Diagnosis of lower respiratory tract infections. What we have and what would be nice
29. Empiric treatments impair the diagnostic yield of BAL in HIV-positive patients
30. Approach to the immunocompromised host with pulmonary symptoms
31. Legionellosis
32. Diagnosis of histoplasmosis in patients with the acquired immunodeficiency syndrome by detection of Histoptasma capsulatum polysaccharide antigen in bronchoalveolar lavage fluid
33. Detection of cryptococcal antigen in bronchoalveolar lavage; A prospective study of diagnostic utility
34. Approaches to fungal diagnosis in transplantation
35. New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients
36. The laboratory evaluation of opportunistic pulmonary infections
37. Invasive Diagnostic techniques for pneumonia: Protected specimen brush, bronchoalveolar lavage, and lung biopsy methods
38. Pathologic outcome in HIV-seropositive individuals with nonspecific bronchoalveolar lavage cytology
39. Open lung biopsy in immunocompromised patients
40. Tests giving an etiological diagnosis in pulmonary disease in patients infected with the human immunodeficiency virus
41. Flexible bronchoscopy in lung transplantation
42. Immunosuppression and incidence of opportunistic pneumonias after liver transplantation
43. Pulmonary complications of bone marrow transplantation
44. Investigation and management of pulmonary infiltrates following bone marrow transplantation: An eight year review
45. The role of open lung biopsy in the management and outcome of patients with diffuse lung disease
46. Evaluation of heart-lung transplant recipients with prospective, serial transbronchial biopsies and pumonary function studies
47. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection
48. Downward trends in bronchoscopies performed between 1991 and 1997
49. Relationship between procedures and health insurance for critically ill patients with Pneumocystis carinii pneumonia
50. Cost and outcome of intensive care for patients with AIDS, Pneumocystis carinii pneumonia, and severe respiratory failure
51. Empiric diagnosis of Pneumocystis carinii pneumonia. Questions of accuracy and equity
52. Empirically treated Pneumocystis carinii pneumonia in Los Angeles, Chicago, and Miami 1987-1990
53. Bronchoscopy versus empirical therapy in HIV-infected patients with presumptive Pneumocystis carinii pneumonia. A decision analysis
54. The relation between physician experience and patterns of care for patients with AIDS-related Pneumocystis carinii pneumonia
55. The use of mucolysed induced sputum for the identification of pulmonary pathogens associated with human immunodeficiency virus infection
56. Cost reduction in diagnosing Pneumocystis carinii pneumonia. Sputum induction versus bronchoalveolar lavage as the initial diagnostic procedure
57. The diagnostic strategy for Pneumocystis carinii pneumonia. Is doing less better than doing more?
58. Performance of an algorithm to detect Pneumocystis carinii in symptomatic HIV-infected persons
59. Controlled utilization of induced sputum analysis in the diagnosis of Pneumocystis carinii pneumonia
60. A comparison of induced and expectorated sputum for the diagnosis of Pneumocystis carinii pneumonia
61. Role of bronchoalveolar lavage in predicting survival of patients with human immunodeficiency virus infection